Filgotinib in the treatment of ulcerative colitis: lessons learned from randomized trial to real-world studies.

Mocci G, Orrù G, Onidi FM, Usai Satta P, Tursi A

Open source

DOI
10.1080/14656566.2026.2750245
Published
2026 Oct 29
Container
Expert opinion on pharmacotherapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14656566.2026.2750245,
  title = {Filgotinib in the treatment of ulcerative colitis: lessons learned from randomized trial to real-world studies.},
  author = {Mocci G and Orrù G and Onidi FM and Usai Satta P and Tursi A},
  year = {2026},
  journal = {Expert opinion on pharmacotherapy},
  doi = {10.1080/14656566.2026.2750245},
  url = {https://doi.org/10.1080/14656566.2026.2750245}
}

RIS

TY  - JOUR
TI  - Filgotinib in the treatment of ulcerative colitis: lessons learned from randomized trial to real-world studies.
AU  - Mocci G
AU  - Orrù G
AU  - Onidi FM
AU  - Usai Satta P
AU  - Tursi A
PY  - 2026
JO  - Expert opinion on pharmacotherapy
DO  - 10.1080/14656566.2026.2750245
UR  - https://doi.org/10.1080/14656566.2026.2750245
ER  - 

APA

G, M., G, O., FM, O., P, U. S., & A, T. (2026). Filgotinib in the treatment of ulcerative colitis: lessons learned from randomized trial to real-world studies.. Expert opinion on pharmacotherapy. https://doi.org/10.1080/14656566.2026.2750245

Source records